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Influenza is often seen as an unprob-lematic and self-limiting disease de-
spite putting a high burden on patients as 
well as being of high socioeconomic rel-
evance to societies [1]. It continues to be 
a considerable health problem in Eu-
rope. Influenza is a major cause of mor-
bidity and mortality affecting up to 25% 
of the population each year [2].  The 
costs of influenza in Germany in 1996 
came to nearly € 2.5 billions. The bulk of 
the indirect costs is due to inability to 
work [1].  The typical case of influenza 
may be characterized by the abrupt on-
set of fever, sore throat, nonproductive 
cough, myalgias, headache, and malaise. 
Symptoms usually last for 5–6 days. El-
derly and other high-risk persons are 
especially vulnerable to the serious com-
plications of influenza [2]. The estimated 
influenza incidence in Germany was 
4 million cases in 1996 [1].
Vaccination is an effective interven-
tion reducing mortality and morbidity 
of influenza especially in elderly and 
patients with high risk conditions [3]. 
Vaccination can prevent about 50% of 
deaths from pneumococcal disease and 
80% of deaths from influenza-related 
complications in the elderly [4]. In ad-
dition to providing substantial health 
benefits, vaccination may also be asso-
ciated with significant economic ben-
efits, not only among the elderly but 
also among healthy working adults and 
even children. Healthy working adults 
traditionally have not been included 
among the priority groups targeted for 
annual influenza vaccination. Fewer 
than 25% of the persons aged between 
18 and 64 years received an influenza 
vaccination during 1997. Nevertheless, 
the effect of influenza on this group is 
also substantial. Influenza vaccination 
of healthy working adults is, on average, 
cost-saving [2].
The German Standing Commis-
sion on Immunization has recom-
mended that the following groups re-
ceive influenza vaccination: (1) persons 
who are ≥ 60 years of age, (2) people 
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ABSTRACT
 Background und Purpose:  Influenza continues to be a considerable health 
problem in Europe.  Vaccination is the only preventive measure, reducing mor-
tality and morbidity of influenza in all age groups. The objectives of this survey 
were to assess the level of influenza vaccination coverage in the 2002/2003 
season compared with the 2003/2004 season in Germany, to understand the 
driving forces and barriers to vaccination, and to determine vaccination inten-
tions for the following winter.
 Methods: The authors conducted a random-sampling, telephone-based 
household survey among noninstitutionalized individuals representative of the 
population aged ≥ 14.  The surveys for 2002/2003 and 2003/2004 used the same 
questionnaire and were subsequently pooled. Four target groups were deter-
mined for analysis: (1) persons aged ≥ 60; (2) people working in the medical field; 
(3) persons suffering from chronic illness;  and (4) a group composed of persons 
aged ≥ 60 or working in the medical field or suffering from a chronic illness.
 Results: The overall sample consisted of 4,011 people. The influenza vacci-
nation coverage rate in Germany increased from 22.3% in 2002/2003 to 25.1% 
in 2003/2004.  This increase is not significant.  The most frequent reasons for 
being vaccinated given by vaccinees were: influenza considered to be a serious 
illness, which people wanted to avoid (90.1%), having received advice from the 
family doctor or nurse to be vaccinated (71.3%), and not wanting to infect fam-
ily and friends (70.4%). Reasons for not being vaccinated mentioned by people 
who have never been vaccinated were: thinking about it, however, not being 
vaccinated in the end (47.7%), not expecting to catch influenza (43.6%), and not 
having received a recommendation from the family doctor to be vaccinated 
(36.6%). Options encouraging influenza vaccination are: recommendation by 
the family doctor or nurse (66.6%), more available information on the vaccine 
regarding efficacy and tolerance (54.2%), and more information available about 
the disease (52.4%).
 Conclusion: The vaccination coverage in the 2003/2004 season increased in 
comparison to the 2002/2003 season, although not significantly. The family 
doctor is the most important source of encouragement for people to be vacci-
nated against influenza. It seems that the public would be more likely to be 
vaccinated if they had more information on the efficacy and tolerance of the 
vaccine, as well as the disease. It is therefore suggested that family doctors be 
better informed on influenza vaccine and the disease itself, so that they can ac-
tively inform their patients on these topics.
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with a higher health risk condition 
(chronic lung, heart, liver and kidney dis-
eases, diabetes and other metabolic dis-
eases, immunodeficiency, HIV infection 
as well as persons living in institutions), 
(3) people with an increased professional 
risk of influenza infection (health care 
professionals, persons who have exten-
sive contacts with the general public as 
well as people at risk of infecting unvac-
cinated persons with a higher health 
risk). Vaccinations are administered free 
of charge [5]. Van Essen et al. showed 
that in the year 2000 in Germany 186 
doses of influenza vaccine were distrib-
uted per 1,000 population [6].
In general, population-based studies 
of influenza vaccination coverage for a 
country do not exist. A Canadian study 
found 13.8% influenza vaccination 
coverage in fall and winter 1990–1991 
[7]. Most studies on influenza vaccina-
tion coverage investigate specific groups 
such as the elderly [8–17], patients from 
general practices [18, 19], or hospital-
ized patients [20].
The primary aim of this study was 
to identify the level of influenza vacci-
nation coverage in the 2002/2003 and 
2003/2004 seasons in Germany. We 
also wanted to know whether coverage 
was associated with demographic pa-
rameters.
The second objective was to un-
derstand the determinants for being 
vaccinated or not and to obtain the 
population’s opinion on influenza and 
vaccination.
A further objective was to exam-
ine the options which encourage peo-
ple to be vaccinated and to find out 
their vaccination intentions for the 
following winter.
Methods
This study is a population-based survey 
performed during two influenza sea-
sons, 2002/2003 and 2003/2004, in 
Germany.  The questionnaire was cir-
culated via telephone omnibus among 
noninstitutionalized individuals repre-
sentative of the population, between 
December and January.
The questions were identical in 
both seasons. The list of possible an-
swers with respect to determining driv-
ing forces and barriers to vaccination, 
as well as encouragements to be vacci-
nated, is inserted in Table 1.
For each respondent, the following 
parameters were collected in the survey: 
gender, age, size of household, house-
hold income, educational level, and 
whether participants work in a medical 
field or suffer from a chronic illness 
(such as heart or lung disease, diabetes, 
or others). As well as studying each pa-
rameter separately, we also defined four 
target groups based on the recommen-
dations in Germany at the time of the 
survey.  The target groups were:
ZUSAMMENFASSUNG
Influenza-Durchimpfungsraten in Deutschland. Eine bevökerungsbezo-
gene Querschnittsuntersuchung der Jahre 2002/2003 und 2003/2004
 Hintergrund und Ziel: Die Influenza ist ein bedeutendes Gesundheitspro-
blem in Europa. Die Impfung ist die einzige präventive Maßnahme, welche die 
Morbidität und Mortalität der Influenza in allen Alterskategorien zu reduzieren 
vermag. Ziele der vorliegenden Untersuchung waren, die Durchimpfungsraten 
in der Saison 2003/2004 zu erheben und mit der Saison 2002/2003 in Deutsch-
land zu vergleichen, die Beweg- and Ablehnungsgründe der Impfung zu verste-
hen sowie die Absicht zu erfassen, im nächsten Jahr geimpft zu werden.
 Methodik: Die Autoren führten eine zufallsgesteuerte Telefonbefragung in 
Haushalten durch. Zielgruppen waren nichtinstitutionelle Personen, repräsen-
tativ für die Alterskategorien ≥ 14 Jahre. Die Untersuchungen der beiden Sai-
sons waren identisch und konnten gepoolt werden. Vier spezifische Zielgrup-
pen wurden für diese Untersuchung definiert: 1. Personen ≥ 60 Jahre, 2. Perso-
nen, die in medizinischen Einrichtungen arbeiten, 3. Personen mit chronischen 
Erkrankungen sowie 4. Personen, die zu einer oder mehreren der Gruppen 1–3 
gehören.
 Ergebnisse: Die Stichprobe umfasste 4 011 Personen. Die Durchimpfungs-
rate in Deutschland nahm von 22,3% in der Saison 2002/2003 auf 25,1% in der 
Saison 2003/2004 zu. Diese Zunahme ist statistisch nicht signifikant. Die häu-
figsten Gründe für eine Impfung waren: 1. Influenza ist eine schwerwiegende 
Erkrankung, welche vermieden werden sollte (90,1%), 2. die Empfehlung des 
Arztes oder einer Krankenschwester, sich impfen zu lassen (71,3%), und 3. die 
Verwandten und Freunde nicht anstecken zu wollen (70,4%). Die Gründe für 
eine Ablehnung der Impfung bei Personen, die noch nie geimpft wurden, wa-
ren: 1. Man denkt daran, aber schlussendlich lässt man sich nicht impfen (47,7%), 
2. man erwartet keine Ansteckung (43,6%), 3. man erhielt keine Empfehlung 
seitens des Arztes oder einer Krankenschwester (36,6%). Die wichtigsten Op-
tionen zur  Veranlassung einer Grippeimpfung sind: 1. Empfehlungen durch den 
Arzt oder die Krankenschwester (66,6%), 2. mehr Informationen hinsichtlich 
der Wirksamkeit und Verträglichkeit der Impfung (54,2%) und 3. mehr Infor-
mationen über die Erkrankung (52,4%).
 Schlussfolgerung: Der Durchimpfungsgrad nahm in der Saison 2003/2004 
im Vergleich zur 2002/2003 zu, obschon nicht signifikant. Der Hausarzt scheint 
der wichtigste Ansprechpartner zu sein, der die Bevölkerung zu einer vermehr-
ten Grippeimpfung motivieren kann. Es scheint, dass die Bevölkerung mehr 
Informationen hinsichtlich der Wirksamkeit und Verträglichkeit der Impfung 
sowie über die Influenza benötigt, um sich impfen zu lassen. Deshalb wird 
Grundversorgern empfohlen, sich weiterhin ausführlich über die Erkrankung 
und die Impfung zu informieren und entsprechend ihre Zielgruppen vermehrt 
zu informieren.
Schlüsselwörter: Influenza · Impfung · Durchimpfungsraten · Deutschland · 
Gesundheitsversorgung 
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•  all individuals ≥ 60 years of age,
•  all individuals who suffer from a 
chronic illness,
•  all individuals who work in the med-
ical field,
•  all individuals aged ≥ 60 or who suf-
fer from a chronic illness or who 
work in the medical field.
The data were pooled and weighted for 
age and gender. The statistical evalua-
tion has been performed with the 
statistic program SPSS (Statistical Pack-
age for the Social Sciences). Bivariate 
associations of categorical variables 
were analyzed using χ2-tests. In case of 
one continuous variable, a t-test or 
Mann-Whitney test was used, depend-
ing on the kind of distribution ob-
served. In all cases, p = 0.05 was used as 
the level of statistical significance. 
Where applicable, odds ratios were cal-
culated from 2 × 2 tables, including 
95% confidence intervals.
Results
Demographic Data
The overall sample consisted of 4,011 
persons. An overview of the sample is 
given in Table 2. The samples are repre-
sentative of the country’s adult popula-
tion.
Vaccination Rate
The vaccination rate for 2002/2003 
was 22.3% and 25.1% for 2003/2004 
(Figure 1). The influenza vaccination 
rate increased by 2.8%. This increase is 
not significant (p = 0.054).
For the subsequent winter 
(2004/2005) 44% of respondents in-
tend to be vaccinated against influenza.
Vaccination Coverage in Target Groups
Pooling both influenza seasons to-
gether, the vaccination coverage rate 
for the group aged ≥ 60 was 45.0%, 
significantly different from the popu-
lation < 60, where the vaccination 
coverage rate reached 14.7% (p = 
0.001; Table 3).
The group suffering from chronic 
illness recorded a significantly higher 
vaccination coverage rate than the 
group not suffering from chronic ill-
ness (39.6% and 20.8%; respectively; 
p = 0.001).
Working in the medical field does 
not seem to be a driving force for vac-
cination, as the vaccination coverage 
rate in this population (18.0%) is lower 
than the coverage rate in the non-med-
ical-professional group (24.1%). The 
difference between the two groups is 
significant (p = 0.029). Concerning the 
people who are ≥ 60 or suffer from 
chronic illness or work in the medical 
field, the vaccination rate is 38.7%. This 
is significantly higher than the people 
not included in that group (13.3%; p = 
0.001).
The vaccination coverage rate is 
not associated with gender, but with 
age. People ≥ 60 have an odds ratio of 
4.7 for being vaccinated versus those 
< 60. The influence of age is also clear-
ly apparent in Figure 2: the older the 
 
Why did you get vaccinated this winter?
• Because it’s free: the Social Security pays for it
• So that I do not pass the flu bug to my family and friends
• Because the flu is a serious illness and I did not want to get it
• The doctor at work offered to do it for me
• My family doctor/nurse advised me to do it
• My pharmacist advised me to do it
• Because of my age
• Because I am not in very good health
• To prevent the flu from interrupting my professional activities
• Because it is required/indicated for my job
• Because I got the flu last year
• Other reasons
• Don’t know/no answer
Why do you not get vaccinated against the flu?
• I don’t think I am very likely to catch the flu
• I thought about it, but I didn’t end up getting vaccinated
• My family doctor has never recommended it to me
• My doctor at work has never recommended it to me
• My pharmacist has never recommended it to me
• It is not a serious enough illness
• I do not think the vaccine is effective enough
• I do not like injections/needles
• I have never considered it before
• There is a new treatment which helps cure the flu
• I am too young to be vaccinated
• I am against vaccinations
• It is too complicated to get vaccinated
• It is too expensive, it is not reimbursed
• Other reasons
• Don’t know/no answer
Which of the following options would encourage you to be vaccinated against 
the flu?
• If I could be vaccinated at work
• If my doctor/nurse recommended it to me
• If my pharmacist recommended it to me
•  If there were other ways of administering the vaccine (orally, injection without a 
needle, etc.)
• If it were cheaper
• If I had more information on the vaccine regarding efficacy and tolerance
• If I knew more about the disease
• I would not change my mind, I would never be vaccinated
• Other
• Don’t know/no answer
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people, the higher the vaccination cov-
erage rate. Comparing the evolution of 
vaccination coverage rate between 
2003/2004 and 2002/2003 for age 
groups, it is striking that all age groups 
< 70 increased vaccination coverage 
rate while there was a decrease for the 
groups aged ≥ 70.
People suffering from chronic ill-
ness have an odds ratio for vaccination 
of 2.5 over people with no chronic 
health problems. Medical professionals 
have less probability of being vaccinat-
ed than people not working in the 
medical field: the odds ratio for vacci-
nation equals 0.7.
Demographics and Vaccination Rates
The education level, the size of house-
hold and the household income have a 
significant influence on vaccination 
coverage (Table 4). People with a low 
income (< 1,000 € per month) have 
a higher vaccination coverage rate 
(31.7%) than those with an income 
≥ 3,000 € per month (17.9%). Our sur-
vey also demonstrates that small house-
holds (one to two members) have less 
influenza vaccine uptake than larger 
households (three or more). People 
with a high school examination have a 
lower vaccination rate than people who 
went to primary school without fur-
ther professional training (15.4% vs. 
33.5%). In our survey, the respondents 
with low social grade (low educational 
level, low income) seemed to be better 
vaccinated than people with high social 
grade.
Questions about the Vaccination
For those who have been vaccinated 
during the last season, the most fre-
quently stated reasons for being vacci-
nated were the fact that influenza is con-
sidered to be a serious illness, which 
people want to avoid (90.1%), advice 
from the family doctor or nurse 
(71.3%), and not wanting to pass flu 
to family and friends (70.4%;  Table 5). 
For those who have never been 
vaccinated, reasons against vaccination 
were the fact that people think about it, 
but do not end up being vaccinated 
(47.7%), not expecting to catch influ-
enza (43.6%), and the fact that the fam-
ily doctor has never recommended it 
(36.6%; Table 6). 
More than 50% of the respondents 
agreed with the following opinions 
about the vaccine:
•  You can catch the flu even if you are 
vaccinated against it.
•  If you catch the flu after having had 
the vaccine, the infection is less se-
vere.
Table 2. Overview of samples.
 Total 1,999 2,012 4,011
Mean age (years) 46.9 46.8 46.8
Age ≥ 60 years 29.6% 29.6% 29.6%
Male 47.8% 47.8% 47.8%
Work in medical field    6.4%    6.4%    6.4%
Chronic illness Not available 23.3% 23.3%
Target group: ≥ 60 or chronic illness  35.4% 46.2% 40.8%
or work in medical field
 2002/2003 2003/2004  Total
Table 3. Vaccination coverage in target groups. CI: confidence interval.
 Gender
• Male 22.5 
• Female 24.7 0.106 1.1 (1.0–1.3)
Age (years)
• < 60 14.7  
• ≥ 60 45.0 0.001 4.7 (4.1–5.5)
Chronic illness
• Yes 39.6
• No 20.8 0.001 2.5 (2.0–3.1)
Work in medical field
• Yes 18.0
• No 24.1 0.029 0.7 (0.5–1.0)
Target group: ≥ 60 or 
chronic illness or work in 
medical field
• Yes 38.7
• No 13.3 0.001 4.1 (3.5–4.8)
aχ2-test
 Vaccination rate (%) p-valuea  Odds ratio (95% CI)
No, never
No, but in the past
Yes, not first time
Yes, first time
%
60
50
40
30
20
10
0
2002/2003
2003/2004
χ2, p = 0.054
3
5252
2322
25
20
Figure 1. Vaccination rate in Germany: Have you had an influenza vaccine this winter?
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•  The side effects associated with the 
vaccine (fever, headache, etc.) are ac-
ceptable.
•  It is important to get the influenza 
vaccine each year.
More than 50% of the participants did 
not agree to the following opinions: 
the vaccine is not useful if you are in 
good health, and if you have the vac-
cine, you will not catch influenza (Ta-
ble 7). 
Options which encourage vacci-
nation against influenza are: recom-
mendation by the family doctor 
(66.6%), more information about the 
vaccine regarding efficacy and toler-
ance (54.2%) and about the disease 
(52.4%; Table 8).
DISCUSSION
This survey has been performed inter-
nationally (France, United Kingdom, 
Italy, Spain, Germany) for two consecu-
tive seasons, 2002/2003 and 2003/2004. 
We believe a telephone survey is an ap-
propriate method in establishing influ-
enza vaccination coverage rates in dif-
ferent groups in the population. It can 
be started at short notice, it is an easy 
way to reach a large number of subjects 
rapidly, does not extend over more than 
a few weeks and can be repeated over 
several influenza seasons.
Several limitations of the present 
evaluation are acknowledged.  The most 
important potential reason of selection 
bias despite correct sampling is nonre-
sponse. Comparisons of face-to-face, 
mailed and telephone surveys address-
ing health-related issues showed small 
differences between modes of adminis-
tration and small nonresponse effects 
with respect to prevalence estimates 
[21, 22]. Nonresponse in telephone 
surveys was found to be less con-
tent-oriented than in mailed surveys 
[23]. Also, bias due to different sociode-
mographic characteristics of persons 
inaccessible by telephone affected re-
ports of illness and related use of ser-
vices only marginally, if the general 
population was addressed and if tele-
phone coverage was at least 90% [21, 
24]. Persons living in institutions could 
not be included, which would be criti-
cal in the study of a disease affecting 
the higher ages differentially or directly 
causing institutionalization. The fact for 
not having asked the chronic illness 
question in season 2002/2003 may 
have impacted chronic illness figures. 
However, it is hypothesized that the 
impact is minimal as the responses 
would have been similar for both sea-
sons. One bias could emerge from 
17
4
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39
52
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17
26
43
45 46
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20
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40
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70
14−19 20−29 30−39 40−49 50−59 60−69 70−79 80−89
Age group (year)
%
2002/2003
2003/2004
χ 2, p = 0.001
Figure 2. Profile of vaccinated population by age groups.
Table 4. Demographics and vaccination rates.
 Size of household (members)
• 1 10.5
• 2 13.1
• 3 26.6
• 4 32.4
• 5 20.2 0.001
Educational level of respondent
• Elementary, primary school  33.5
    without further professional training 
•  Elementary, primary school  25.8
    with further professional training
•  Intermediate, high school  23.6
    without high school examination
•  High school examination;  15.4
qualification for the technical college
• Higher education (university,  28.2
    academy, technical college)
•  Still go to school 25.4 0.003
Household income per month
• < 1,000 € 31.7  
• 1,000 up to < 1,500 € 27.5
• 1,500 up to < 2,000 € 28.9
• 2,000 up to < 2,500 € 20.5
• 2,500 up to < 3,000 € 21.0
• ≥ 3000 € 17.9 0.001
aχ2-test
 Vaccination rate (%)   p-valuea
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over- or underreporting of chronic ill-
ness.
We estimate, for Europe, that ap-
proximately 22% and 23% of the popu-
lation studied > 15 years of age had 
received influenza vaccination for the 
2002/2003 and 2003/2004 influenza 
seasons, respectively [25]. This percent-
age corresponds approximately to the 
20% maximum estimate for the immu-
nization rate for the entire population 
calculated from the number of vaccine 
doses sold for the 2002–2004 immuni-
zation period, assuming all doses sold 
were given (90 million doses for the 
2002–2004 influenza vaccination peri-
od in Europe; data provided by the 
suppliers) [26].
Vaccination coverage in Germany 
increased during the 2003/2004 season 
relative to the 2002/2003 season (25.1% 
vs. 22.3%), but the increase is not statis-
tically significant. One of the major ex-
planations of this increase can be seen 
in the increased efforts from the Ger-
man health authorities to inform their 
people on the dangers of influenza.
People who were previously vacci-
nated picked up vaccination again 
while first-time users increased in par-
ORIGINALARBEIT
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Table 5. Questions asked to the population who has been vaccinated: “Why did you get vaccinated this winter?” The most frequently stated reasons (%).
 Because influenza is a serious illness and I did not want to get it 90.1a 86.9a 88.9a 92.3a
My family doctor/nurse advised me to do it 71.3a 48.1 76.3a 76.3a
So that I do not pass the influenza bug to my family and friends 70.4a 53.4a 70.8a 66.8a
Because of my age 40.3 27.4 39.8 56.9
Because it’s free: the Social Security pays for it 34.5 45.8 29.3 27.7
Because I am not in very good health 29.2 23.2 48.0 35.8
To prevent influenza from interrupting my professional activities 26.5 40.2 17.8   9.6
Because it is required/indicated for my job 19.0 68.1a 14.8   6.6
The doctor at work offered to do it for me 14.9 34.4    8.4 10.2
amain three reasons stated amongst the different groups 
 All  Medical staff Chronic illness   ≥ 60 years
Table 6. Questions asked to the population who has never been vaccinated: “Why do you not get vaccinated against influenza?” The most frequently 
stated reasons (%).
 I thought about it, but I didn’t end up getting vaccinated 47.7a 42.0a 49.9a 48.1a
I don’t think I am very likely to catch the flu 43.6a 43.9a 36.0a 45.7a
My family doctor has never recommended it to me 36.6a 43.3a 27.8 29.3
It is not a serious enough illness 36.2 38.7 31.9a 29.5
My pharmacist has never recommended it to me 34.9 37.4 25.4 15.7
I have never considered it before 30.8 27.4 28.6 31.9a
I do not like injections/needles 30.5 22.0 29.0 25.1
I do not think the vaccine is effective enough 27.7 31.0 29.1 26.1
My doctor at work has never recommended it to me 21.2 36.1 14.4    9.9
amain three reasons stated amongst the different groups 
 All Medical staff Chronic illness   ≥ 60 years
Table 7. Opinions about influenza vaccine (%).
You can catch influenza even if you are vaccinated against it 33.9 44.8 13.8  5.7 1.8
If you catch influenza after having had the vaccine, the infection is  27.6 41.3 17.7  9.3 4.1
less severe
The side effects associated with the vaccine (fever, headache, etc.) 24.3  37.6 21.5 10.6 6.0
are acceptable
If you have the vaccine, you won’t catch influenza   8.5 25.7 36.8 27.2 1.8
The influenza vaccine is not useful if you are in good health 17.6 26.4 29.2 25.5 1.3
It is important to get the flu vaccine each year 25.9 28.3 29.4 15.4 1.0
   Totally  Quite Don’t really Don’t  Don’t
 agree  agree  agree agree at all    know
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allel (Figure 1). To be noted is that the 
increase is situated in all but two age 
groups (70–79 and 80–89). This means 
that the uptake of influenza vaccination 
was more pronounced in the age popu-
lation not recommended for vaccina-
tion (people < 60) than in the age-pop-
ulation recommended for vaccination 
(people ≥ 60). Regarding the surveyed 
populations across Europe, the German 
population ≥ 14 has the highest vacci-
nation coverage rate in Europe. This is 
due to a higher than average uptake in 
the adult working population when 
compared with other European coun-
tries. By contrast, the population ≥ 60 
has the lowest vaccination coverage in 
Europe [25].
For the subsequent winter (2004/ 
2005) 44% of the individuals surveyed 
intend to be vaccinated against influ-
enza. This is higher than the current 
overall population coverage rate, im-
plying that more people intend to be 
vaccinated during the winter 
2004/2005 than were vaccinated dur-
ing winter 2003/3004.
The most important predisposing 
factors affecting vaccination rate are 
age (being old) and suffering from 
chronic illness. These two groups of 
people are also the two main target 
groups mentioned in the German rec-
ommendations. This demonstrates that 
the German doctors identify the peo-
ple which need vaccination. Kamal et 
al. also showed that comorbidities in-
fluence vaccination rate [4]. Other fac-
tors influencing vaccination are size of 
household, household income, and ed-
ucational level.
The assumption that health care 
workers have a higher vaccination rate 
than non-health care workers is not the 
case in Germany. The health care pro-
fessionals’ vaccination rate is low (18%). 
Rehmet et al. showed this tendency as 
well (7% of health care workers in 1999 
were immunized) [5]. This is opposite 
to the fact that the health care profes-
sionals are at increased risk of influenza 
infection and could potentially trans-
mit the disease to fragile patients in 
hospitals.
The survey demonstrated that there 
are some clear reasons driving vaccina-
tion for people who had an influenza 
vaccine. The three most important 
mentioned were: influenza being con-
sidered a serious illness, family doctor 
or nurse actively recommending it, and 
not wanting to pass flu to family and 
friends. The three main reasons for not 
being vaccinated noted by those who 
have never been vaccinated were: 
thinking about it but not being vacci-
nated in the end, not expecting to catch 
influenza, and not being recommended 
to have a vaccination by the family 
doctor or nurse.
Both those being vaccinated and 
those who have never been vaccinated 
note the doctor or nurse as people 
playing a key role in public vaccination 
behavior. In the vaccinated group, 
health care professionals were able to 
stimulate their patients toward vaccina-
tion by active recommendation where-
as in the nonvaccinated group, omitting 
to recommend vaccination had a nega-
tive effect on uptake. This clearly indi-
cates the key role of health care work-
ers in vaccination uptake.
The family doctor is the most im-
portant person to encourage people to 
be vaccinated against influenza; this was 
also confirmed by Kamal et al. [4], Kro-
neman et al. [3], and Rehmet et al. [5]. 
Rehmet et al. demonstrated that hav-
ing a family doctor increased the vac-
cination rate and that family physicians 
performed 93% of the vaccinations. 
This indicates that active recommenda-
tion from the family doctor could re-
ally impact vaccine uptake. This is con-
firmed by the surveyed people them-
selves, who state that an active recom-
mendation by their doctor would 
indeed encourage them to be vacci-
nated (Table 8).
Further referring to Table 8 shows 
that the patients would like more in-
formation on influenza as a disease and 
on influenza vaccines, so as to be vac-
cinated. We therefore suggest that fam-
ily doctors be better informed about 
the influenza vaccine and the disease 
itself, so that they can actively inform 
their patients about these topics and 
recommend vaccination accordingly. 
This could lead to an increase in vac-
cine uptake.
In May 2003, through the World 
Health Assembly, the WHO passed a 
resolution on prevention and control of 
influenza pandemics and annual epi-
demics. The resolution urges member 
states where national influenza recom-
mendations for people at risk (elderly 
and persons with underlying diseases) 
exist, to attain a vaccination coverage 
rate in the elderly of 50% in 2006 and 
75% in 2010 (Resolution of the World 
Health Assembly WHA 56.19, Preven-
tion and control of influenza pandem-
ics and annual epidemics, 56th WHA, 
10th plenary meeting, May 28, 2003).
In the context of this paper, we 
compared this objective with the situa-
Table 8. Questions about the vaccination. Options encouraging to be vaccinated against influenza (%).
If my family doctor/nurse recommended it to me 66.6a 55.0a 70.4a 71.9a
If I had more information on the vaccine regarding efficacy and tolerance 54.2a 44.0a 54.1a 49.0a
If I knew more about the disease 52.4a 39.6 50.8a 48.4a
If it were cheaper or reimbursed 42.0 36.6 44.7 36.5
If I could be vaccinated at work 39.8 48.3a 36.7 28.1
If there were other ways of administering the vaccine  39.3 29.3 40.0 40.2 
(orally, injection without a needle, etc.)
If my pharmacist recommended it to me 29.8 24.4 35.5 36.2
amain three reasons stated amongst the different groups
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tion in Germany, considering that the 
elderly population was the population 
recommended for vaccination (i.e., 
those aged ≥ 60). When referring to 
Figure 2, the current situation in Ger-
many is far from matching this objec-
tive. Only the ≥ 70 years of age match 
the 50% for 2006 (and only during 
2002/2003). The 60–69 are well under 
that objective. The situation is worse 
for 2003/2004, where no elderly group 
matches the 50% objective. In Europe, 
Germany is the country with the low-
est vaccination coverage rate of the el-
derly population [26]. A lot of efforts to 
increase vaccination coverage rate will 
therefore be necessary to match this 
objective. A stronger implementation 
of the current recommendations is 
needed: doctors should be made aware 
of their importance in this process. To 
improve the situation, doctors need to 
be educated on influenza and influenza 
vaccine benefits in order to be vacci-
nated themselves first. Then, they need 
to be informed on the fact that they 
should actively recommend the vac-
cine, as well as inform their patients on 
influenza and influenza vaccine. Active 
recommendation to the target groups 
in the recommendations could really 
impact vaccine uptake in these at-risk 
groups. They should also be made aware 
of the fact that patients are in demand 
for information on the diseases and 
vaccines. In general, more education on 
disease and influenza vaccine benefits 
should be made available.
These results are consistent with 
other studies showing the importance 
of physicians or health care personnel 
in motivating people for influenza vac-
cination [3, 7, 11, 12].
Efforts must be made at all national 
and international levels to increase the 
coverage according to the WHO ob-
jectives. Further research should be 
performed to provide consistent com-
parison between different countries 
and seasons over time.
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